SMTL ID : 8i7t.2 (1 other biounit)

The crystal structure of human abl1 kinase domain in complex with ABL1-B4

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x 6I5: [3-[5-[5-(dimethylcarbamoyl)pyridin-3-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-methoxy-phenyl] ethanesulfonate(Covalent)

6I5.1: 19 residues within 4Å: Chain A: L.20, G.22, Q.24, Y.25, V.28, A.41, K.43, E.58, V.71, I.85, T.87, E.88, F.89, M.90, G.93, N.94, L.142, A.152, F.154 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:L.20, A:Y.25, A:V.28, A:K.43, A:L.142, A:L.142 Hydrogen bonds: A:Y.25, A:T.87, A:E.88, A:M.90, A:N.94, A:N.94 Salt bridges: A:K.43

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sun, J. et al., Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies. J Adv Res (2024)

Release Date

2024-10-23

Peptides

Tyrosine-protein kinase ABL1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein kinase ABL1

Related Entries With Identical Sequence